{
    "2019-03-25": [
        [
            {
                "time": "",
                "original_text": "【增减持】药明康德(02359.HK)遭摩根大通减持3.3万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "摩根大通",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：中国区业务和投资收益推进利润增长",
                "features": {
                    "keywords": [
                        "药明康德",
                        "利润增长",
                        "投资收益"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:科创板大幕徐徐拉开，医药股主线机会凸显",
                "features": {
                    "keywords": [
                        "医药生物",
                        "科创板",
                        "医药股",
                        "机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：创新型药企有望迎来估值重塑 荐4股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "创新型药企",
                        "估值重塑"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "药明康德：增长强劲 凸显龙头气质",
                "features": {
                    "keywords": [
                        "药明康德",
                        "增长强劲",
                        "龙头气质"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【中信建投医药】药明康德(603259)：深度整合全球资源，全面赋能创新平台",
                "features": {
                    "keywords": [
                        "中信建投",
                        "药明康德",
                        "资源整合",
                        "创新平台"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}